Skip to content
Back to Guavy Wire
Stocks

P&G Buys Supplement Maker Thorne in $3.8 Billion Deal

Instruments
PG
Share

Procter & Gamble (P&G) has acquired Thorne, a supplement maker, for $3.8 billion. This move is part of P&G's expansion into the health and wellness business, which already includes brands such as Metamucil, Align Probiotic, and New Chapter vitamins.

P&G aims to own premium, relevant brands that younger shoppers care about. Thorne has been around for decades and has seen significant growth in recent years, with its customer base skewing young and more sales coming directly from consumers online.

The acquisition follows a pattern of big consumer companies buying trendy supplement brands. Unilever bought Grüns earlier this year. P&G's goal is to tap into the growing market for vitamins and supplements, which has been gaining popularity as people seek products to help with sleep and energy.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc